Urinary System Neoplasm — Trials

Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,240 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 343 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06099782	A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)	active not recruiting	Phase 2	147	Merck Sharp & Dohme LLCINDUSTRY	10	Apr 8, 2026	clinicaltrials
NCT00579514	Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients	active not recruiting	N/A	21,081	Memorial Sloan Kettering Cancer CenterOTHER	1